← IV and Infusion Therapies main guide
What is IV Curcumin?
IV curcumin is not established as a routine treatment for inflammation or cancer; it is an experimental application that must be evaluated within the framework of clinical research and product safety.
How does it work?
Its effects on NF-kB and various inflammatory signaling pathways are being investigated at the laboratory level; clinical outcomes depend on formulation and bioavailability.
In which situations can it be considered?
Tolerability and pharmacokinetics have been investigated in early-phase studies. It is not a substitute for standard treatment and can only be considered in the context of appropriate research or specific clinical evaluation.
Level of evidence
D – experimental.
Safety and patient selection
Formulation, solvent, liver function, drug interactions, and infusion reactions are important. No dose should be recommended without product verification.
Our Approach at Our Bodrum Clinic
We consider this application only after the pharmaceutical properties of the product have been verified and the patient’s medical history, current medications, kidney and liver functions, necessary electrolyte-micronutrient measurements, and relevant contraindications have been evaluated. We plan IV therapy not as an alternative to standard treatment, but as a complementary or replacement approach when a genuine clinical rationale exists.
Important note
This page is for general informational purposes; it is not a personal diagnosis, prescription, or administration protocol. An application should not be planned without verifying the label, concentration, excipient, licensing, stability, and compatibility information of the IV product.
